Comparative Study of Postoperative Surgical Site Infections in Diabetic and Non-Diabetic Patients

Active, not recruitingOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

February 28, 2026

Conditions
Surgical Site Infection
Interventions
DIAGNOSTIC_TEST

Diabetic Patients

"This group consists of 66 adult diabetic patients (Type 1 or Type 2) undergoing elective general surgical procedures. These patients will be managed as per standard clinical protocols, including preoperative evaluation, glycemic control assessment (via recent HbA1c and blood glucose levels), and administration of prophylactic broad-spectrum antibiotics-typically second-generation cephalosporins and metronidazole.~Postoperative follow-up will be conducted on Day 1, Day 7, and Day 14 to monitor for the development of surgical site infections (SSIs), which will be classified by the unit chief as superficial, deep, or organ/space infections."

DIAGNOSTIC_TEST

Non-Diabetic Patients

This group includes 66 adult non-diabetic patients undergoing elective general surgical procedures at DHQ Hospital, Dera Ismail Khan. These participants will serve as the comparison group for evaluating the incidence and characteristics of postoperative surgical site infections (SSIs). All patients will receive standard preoperative assessments and prophylactic antibiotics (second-generation cephalosporins with metronidazole) as per institutional protocols. Postoperative follow-up will be carried out on Day 1, Day 7, and Day 14, and SSIs, if any, will be classified based on CDC criteria into superficial, deep, or organ/space infections

Trial Locations (1)

Unknown

DHQ Hospital, Dera Ismāīl Khān

All Listed Sponsors
lead

Superior University

OTHER